Neurosurgery in India

Every neurosurgical brochure lists the same equipment: neuro-navigation, intra-operative MRI, Gamma Knife, CyberKnife. The list is real, and it is also close to meaningless on its own. What determines how a brain operation goes is the surgeon's judgement about how much to remove and when to stop — and, for tumours near speech or motor areas, whether the unit has the anaesthetic and monitoring team to do the operation with you awake.

So the question worth asking is narrower than "does this hospital have an iMRI". It is: how many of this specific operation does this surgeon do a year, and does this unit routinely run awake craniotomies and intra-operative neuromonitoring? Those two answers separate units far more reliably than the equipment inventory does.

Our partner neuro units handle tumour surgery — gliomas, meningiomas, pituitary adenomas via the endoscopic endonasal route, acoustic neuromas — along with aneurysm clipping and endovascular coiling, arteriovenous malformations, surgery for drug-resistant epilepsy including temporal lobectomy, deep brain stimulation for Parkinson's, hydrocephalus shunting and endoscopic third ventriculostomy, and the paediatric neurosurgical range.

Radiosurgery deserves a note of its own. Gamma Knife and CyberKnife are not smaller versions of open surgery; they are a different treatment with different indications. For small acoustic neuromas, some metastases and certain AVMs they are genuinely the better option. For a large tumour causing pressure, they are not an alternative at all. If someone offers you radiosurgery for a lesion that is compressing brain tissue, get another opinion.

Neurosurgical capacity is the practical draw. India trains a large number of neurosurgeons and its major units operate daily, so a tumour that would sit on a list for months elsewhere gets a date in weeks. For a growing lesion, the calendar is not an administrative detail — it is part of the clinical picture.

Cost follows the same pattern as the rest of Indian surgery. A craniotomy for tumour that runs $50,000-$100,000 in the United States is typically $4,500-$8,000 here, and aneurysm treatment shows a similar gap. Because neurosurgical admissions can extend unpredictably, the ratio matters more in this field than in most: an extra week of neuro-ICU is survivable financially here in a way it often is not elsewhere.

The units we work with also do the unglamorous part properly — neuro-rehabilitation. After tumour or stroke surgery, physiotherapy, speech therapy and occupational therapy are what convert a technically successful operation into a functional recovery, and having them in the same building rather than referred out three weeks later makes a measurable difference.

The caution here is specific: not every brain lesion should be operated on. A brainstem tumour, a diffuse low-grade glioma in an eloquent area, or an incidental small meningioma in an elderly patient may be better watched or irradiated. A surgeon who recommends observation is not being unhelpful.

Outcomes depend on the individual case. Ask the treating specialist what to expect for you.

Craniotomy for tumour removal typically runs $4,500-$8,000. Endoscopic pituitary surgery falls around $4,000-$6,500. Aneurysm clipping is usually $5,000-$8,000, while endovascular coiling is often higher — $7,000-$12,000 — because the coils and flow diverters themselves are expensive. Gamma Knife or CyberKnife radiosurgery generally runs $4,000-$7,000 per session, and a VP shunt around $2,500-$4,000.

Neurosurgery is the specialty where the gap between quote and final bill opens most often, because ICU stay is the variable. Ask what the daily neuro-ICU rate is beyond the packaged days, and what a return to theatre would cost. A unit that answers precisely has thought about it before.